Ehsan Zaboli

533 total citations
48 papers, 283 citations indexed

About

Ehsan Zaboli is a scholar working on Oncology, Immunology and Genetics. According to data from OpenAlex, Ehsan Zaboli has authored 48 papers receiving a total of 283 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Oncology, 10 papers in Immunology and 7 papers in Genetics. Recurrent topics in Ehsan Zaboli's work include Chronic Lymphocytic Leukemia Research (7 papers), Cancer survivorship and care (6 papers) and CAR-T cell therapy research (5 papers). Ehsan Zaboli is often cited by papers focused on Chronic Lymphocytic Leukemia Research (7 papers), Cancer survivorship and care (6 papers) and CAR-T cell therapy research (5 papers). Ehsan Zaboli collaborates with scholars based in Iran, United States and Germany. Ehsan Zaboli's co-authors include Hossein Asgarian‐Omran, Omolbanin Amjadi, Mohsen Tehrani, Ghasem Janbabai, Akbar Hedayatizadeh‐Omran, Ebrahim Salehifar, Reza Alizadeh‐Navaei, Ameneh Yaghoobzadeh, Hamid Sharif Nia and Ahmad Reza Taheri and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Life Sciences.

In The Last Decade

Ehsan Zaboli

42 papers receiving 274 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ehsan Zaboli Iran 9 105 63 60 45 43 48 283
Ghasem Janbabaei Iran 9 132 1.3× 29 0.5× 41 0.7× 37 0.8× 19 0.4× 27 281
Luiza Akria Israel 9 99 0.9× 68 1.1× 20 0.3× 16 0.4× 51 1.2× 30 296
Joanna Peng United States 12 88 0.8× 87 1.4× 77 1.3× 20 0.4× 34 0.8× 14 404
Reo Tanoshima Japan 13 65 0.6× 36 0.6× 85 1.4× 41 0.9× 20 0.5× 40 456
Lovorka Đerek Croatia 11 59 0.6× 105 1.7× 179 3.0× 21 0.5× 39 0.9× 36 409
Margaret Cupit-Link United States 6 55 0.5× 19 0.3× 39 0.7× 44 1.0× 43 1.0× 12 270
Markus S. Jördens Germany 11 78 0.7× 36 0.6× 49 0.8× 51 1.1× 17 0.4× 37 320
Klára Gadó Hungary 9 88 0.8× 62 1.0× 102 1.7× 23 0.5× 10 0.2× 30 313
Katherine Tkaczuk United States 9 161 1.5× 17 0.3× 105 1.8× 42 0.9× 15 0.3× 18 326
Sarah I. Ramírez United States 6 36 0.3× 72 1.1× 139 2.3× 39 0.9× 10 0.2× 13 354

Countries citing papers authored by Ehsan Zaboli

Since Specialization
Citations

This map shows the geographic impact of Ehsan Zaboli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ehsan Zaboli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ehsan Zaboli more than expected).

Fields of papers citing papers by Ehsan Zaboli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ehsan Zaboli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ehsan Zaboli. The network helps show where Ehsan Zaboli may publish in the future.

Co-authorship network of co-authors of Ehsan Zaboli

This figure shows the co-authorship network connecting the top 25 collaborators of Ehsan Zaboli. A scholar is included among the top collaborators of Ehsan Zaboli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ehsan Zaboli. Ehsan Zaboli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Amjadi, Parisa, et al.. (2025). Total IgE levels in patients with hematologic malignancies. World Allergy Organization Journal. 18(5). 101050–101050.
2.
Hessami, Amirhossein, et al.. (2025). Depression, anxiety, and stress in breast cancer patients: prevalence, associated risk factors, and clinical correlates. Scientific Reports. 15(1). 31084–31084.
3.
4.
Nia, Hamid Sharif, et al.. (2024). A validity and reliability evaluation of fear of progression questionnaire in Iranian breast cancer patients: A methodological study. Health Science Reports. 7(7). e2260–e2260. 1 indexed citations
5.
Saghafi, Fatemeh, Ebrahim Salehifar, Pouneh Ebrahimi, et al.. (2023). Evaluation of the effect of CYP2D6*3, *4,*10, and *17 polymorphisms on the pharmacokinetic of tamoxifen and its metabolites in patients with hormone-positive breast cancer. Journal of Pharmaceutical and Biomedical Analysis. 238. 115839–115839. 1 indexed citations
6.
Amjadi, Omolbanin, et al.. (2023). Dopamine receptors gene overexpression in the microenvironment of invasive gastric cancer and its potential implications. Molecular Biology Reports. 50(8). 6529–6542. 7 indexed citations
7.
Asgarian‐Omran, Hossein, et al.. (2022). Combined Blockade Of PD-1 and TIGIT is not Sufficient to Improve the Function Of CD8+ T-Cells in Chronic Lymphocytic Leukemia. Asian Pacific Journal of Cancer Prevention. 23(7). 2225–2231. 7 indexed citations
8.
Mousavi, Seyed Abbas, Jamshid Yazdani Charati, Majid Saeedi, et al.. (2021). Association between COVID-19 Infection and ABO Blood Types in Mazandaran Province, Iran: A Cross-Sectional Study.. SHILAP Revista de lepidopterología. 31(197). 35–43. 1 indexed citations
9.
Zaboli, Ehsan, et al.. (2021). Lymphopenia and lung complications in patients with coronavirus disease‐2019 (COVID‐19): A retrospective study based on clinical data. Journal of Medical Virology. 93(9). 5425–5431. 12 indexed citations
10.
Avan, Razieh, Jafar Âkbari, Ghasem Janbabaei, et al.. (2021). Malus domestica reduces chemotherapy-induced nausea and vomiting. Journal of Research in Medical Sciences. 26(1). 72–72. 3 indexed citations
11.
Alizadeh‐Navaei, Reza, Majid Saeedi, Reza Valadan, et al.. (2020). Laboratory Abnormalities in Patients with COVID-19 in Mazandaran Province, Iran. Iranian Red Crescent Medical Journal. 22(7). 1 indexed citations
12.
Elyasi, Forouzan, et al.. (2020). Coping Strategies-Oriented Interventions in Breast Cancer Women: A Systematic Scoping Review of the Quantitative Evidence. Iranian Journal of Psychiatry and Behavioral Sciences. 14(2). 6 indexed citations
13.
Taghiloo, Saeid, Masoud Aliyali, Ali Sharifpour, et al.. (2020). Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID‐19 patients: Clinical and laboratory characteristics. Journal of Medical Virology. 93(3). 1589–1598. 42 indexed citations
14.
15.
Jafari, Narjes, Saeid Abediankenari, Zahra Hosseini‐khah, et al.. (2020). Expression patterns of seven key genes, including β-catenin, Notch1, GATA6, CDX2, miR-34a, miR-181a and miR-93 in gastric cancer. Scientific Reports. 10(1). 12342–12342. 10 indexed citations
16.
Janbabai, Ghasem, et al.. (2019). Epidemiology of hematopoietic cancers in north of Iran: results of Mazandaran population based cancer registry. SHILAP Revista de lepidopterología. 2 indexed citations
17.
Aminian, Ali, et al.. (2019). Breast Cancer, a Well-treated Medical Issue by Rhazes. SHILAP Revista de lepidopterología. 1 indexed citations
18.
Elyasi, Forouzan, et al.. (2019). Effect of Non- Pharmacological Interventions on Stressof Women with Breast Cancer Undergoing Chemotherapy:A Systematic Review. Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Māzandarān/Journal of Mazandaran University of Medical Sciences. 29(178). 167–180. 1 indexed citations
19.
Moosazadeh, Mahmood, et al.. (2019). Association between Anthropometric Indices and Breast Cancer Based on the Data of the Enrolment Phase (cross-sectional) in Tabari Cohort Study: The Causal Relationship or Violation of Temporality. SHILAP Revista de lepidopterología. 29(174). 64–71. 1 indexed citations
20.
Makhlough, Atieh, Zahra Kashi, Ozra Akha, Ehsan Zaboli, & Jamshid Yazdani Charati. (2014). Effect of Spironolactone on Diabetic Nephropathy Compared to the Combination of Spironolactone and Losartan. Nephro-Urology Monthly. 6(1). e12148–e12148. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ghasem Janbabaei Breakdown of academic impact, for papers by Luiza Akria Breakdown of academic impact, for papers by Joanna Peng Breakdown of academic impact, for papers by Reo Tanoshima Breakdown of academic impact, for papers by Lovorka Đerek Breakdown of academic impact, for papers by Margaret Cupit-Link Breakdown of academic impact, for papers by Markus S. Jördens Breakdown of academic impact, for papers by Klára Gadó Breakdown of academic impact, for papers by Katherine Tkaczuk Breakdown of academic impact, for papers by Sarah I. Ramírez
Rankless by CCL
2026